Trademark applications and grants for Dyax Corp. Dyax Corp has 99 trademark applications. The latest application filed is for "TAKZYROH"
Patent Application | Date |
---|---|
ACTRIIB BINDING AGENTS AND USES THEREOF 20220098309 - 17/245526 Kumar; Ravindra ;   et al. | 2022-03-31 |
EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION 20210322972 - 17/102509 Sexton; Daniel J. ;   et al. | 2021-10-21 |
FC RECEPTOR BINDING PROTEINS 20210309741 - 17/203816 Sexton; Daniel J. ;   et al. | 2021-10-07 |
PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM 20210285962 - 16/333155 Sexton; Daniel J. ;   et al. | 2021-09-16 |
IMMUNOASSAY TO DETECT CLEAVED HIGH MOLECULAR WEIGHT KININOGEN 20210270842 - 17/141690 Sexton; Daniel J. ;   et al. | 2021-09-02 |
NCAGE Code | 5XH91 | DYAX CORP. |
CAGE Code | 5XH91 | DYAX CORP. |
SEC | 0000907562 | DYAX CORP of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.